Dear readers, the Singapore stock market continues to be a fascinating stage for investors, traders, and market observers alike. The first half of 2025 was filled with optimism, cautious excitement, and surprising outcomes — and the past two days alone have perfectly exemplified this blend of hope and reality.
While one of the most anticipated IPOs in Singapore’s recent memory — NTT Data Centre REIT (NTT DC REIT) — slipped below its IPO offer price shortly after listing, a lesser-known counter, China Medical System Holdings, made a bold entrance with a rally on debut.
Let’s explore what’s going on and more importantly, what these developments may mean for Singapore investors going forward.
NTT DC REIT: Anticipated Star, but Underwhelming Price Action
On 16 July 2025, NTT DC REIT closed at $0.975, down 2.5% from its IPO offer price of $1.00. Despite being 9.8 times oversubscribed during its public tranche, and widely touted as the “next data centre REIT gem” to join the SGX, its first two days of trading were underwhelming at best.
Day 1 Performance: Flat Start, Muted Enthusiasm
On its debut on 15 July 2025, the REIT closed flat at $1.00, despite strong institutional and retail investor demand. Many investors who were allocated shares in the IPO might have expected a strong debut premium — a quick win. But that didn’t materialize. There was neither a significant price spike nor a large volume breakout. Instead, the REIT saw measured trading, with more sellers than buyers in the aftermarket.
This initial lacklustre performance raises questions about whether the IPO was simply priced to perfection — or slightly overpriced in view of the current interest rate environment and market sentiment.
Day 2: Below IPO Price
The second day was more sobering. NTT DC REIT fell by 2.5% to $0.975, pushing it below IPO price. For many retail investors who bought into the IPO hype, this would be disappointing. For those who bought on debut hoping for momentum trading gains, it likely translated into quick paper losses.
Why did the REIT dip? Some possible reasons include:
- Profit-taking by institutional or large investors.
- Retail disappointment, triggering small-lot exits.
- Valuation concerns, given higher-for-longer interest rate expectations.
- Limited excitement post-listing, as broader market participants focused on more volatile, growth-oriented counters.
But while short-term price movement may be disheartening, REITs are typically longer-term plays. NTT DC REIT is no exception.
The Case for Patience: Long-Term View of NTT DC REIT
Despite its weak start, NTT DC REIT still has longer-term strengths that investors should not overlook:
- Backed by NTT Group, one of the world’s largest telecommunications companies, with a vast and growing network of data centre operations.
- Focused on high-growth data centre assets, which are increasingly seen as essential infrastructure for the digital economy.
- Geographically diversified portfolio, spanning Japan, the UK, the US, and other markets.
- Resilient cash flows and long lease tenures, which appeal to income-focused investors.
- Stability and transparency associated with Singapore REIT governance.
So while short-term market sentiment may be uninspiring, long-term investors could view this early dip as an opportunity rather than a warning.
China Medical System Holdings: Quiet Entrant, Loud Performance
In sharp contrast to NTT DC REIT’s debut, China Medical System Holdings, which listed on SGX on 15 July 2025, surged 11.2% on its first trading day, closing at $2.28.
This was an impressive performance, particularly because:
- It received far less media hype compared to NTT DC REIT.
- It is already dual-listed in Hong Kong, making the SGX listing more of a strategic expansion.
- Investors were uncertain about the impact of China-exposed stocks on SGX.
Day 2 Pullback
Interestingly, on 16 July 2025, the stock gave back some of its gains, closing 5.26% lower at $2.16. But even after this correction, it remained well above its IPO price of $2.05.
This volatility reflects how investors are still digesting the company’s business model, cross-border exposure, and valuation. But the strong debut is indicative of latent interest in Chinese healthcare plays among Singapore investors — especially those offering growth, dividend potential, and diversification away from traditional REITs and banks.
Singapore Stock Market: Resilient Despite Delistings
Beyond the action in individual IPOs, it’s important to zoom out and understand where the broader Singapore stock market stands.
As of mid-July 2025, the Straits Times Index (STI) hit a record high of 4,132.25, a remarkable performance that defies the concerns over multiple stock delistings and low retail trading volumes.
What’s fueling this rally?
1. Equities Review Committee (ERC) Reforms
The Singapore Exchange (SGX), under the guidance of the Equities Review Committee, has implemented and proposed multiple market structure reforms, including:
- Streamlining of listing processes.
- Improvements in corporate governance.
- Strengthening of disclosure requirements.
- Incentives to attract more institutional liquidity.
These measures are meant to reinvigorate the equity market and make SGX a more attractive listing and trading venue. While it’s still early days, investor sentiment has clearly benefited.
2. Strong Sector Performances
Key sectors, including banking, real estate, and transport, have rallied. Stocks like OCBC, UOB, and SIA have hit new highs or are hovering near them. The recent earnings cycle showed profit resilience, even amidst high inflation and geopolitical uncertainty.
3. New IPO Pipeline
Investors are also excited by the new IPO pipeline, with 4 IPOs launched year-to-date, and more expected in the second half of 2025. The listings of NTT DC REIT and China Medical System Holdings have signaled that the IPO engine is back in motion — albeit with a selective investor base.
IPO Lessons: What Can Singapore Investors Learn?
The recent IPO activity provides several key takeaways:
1. Hype ≠ Returns
NTT DC REIT showed that even a highly anticipated, oversubscribed IPO can underperform if valuation is stretched or market sentiment turns cautious. Investors must always dig deeper than media coverage.
2. Under-the-radar Can Win
China Medical System Holdings, though less hyped, outperformed because its valuation was more reasonable, and its growth story more compelling in the short term. Sometimes, quiet listings deliver the best returns.
3. Volatility Remains High
Both counters showed that post-IPO price action is unpredictable. IPO investing is not a guaranteed win, and short-term gains can easily flip into losses. Caution and research are essential.
4. Fundamental View Matters More Than Debut Day
Whether a stock dips or rallies on day one should not be the only metric. Long-term business strength, balance sheet, sector outlook, and dividend policy matter more. Investors should look at 5-year potential, not 5-hour price moves.
What Should Singapore Investors Do Now?
In light of all this, what is the best strategy for retail investors?
1. Stick to a Diversified Portfolio
While IPOs can be exciting, they should not dominate your portfolio. Maintain exposure to blue chips, dividend stocks, REITs, growth counters, and overseas ETFs to manage risk.
2. Use IPOs Strategically
Treat IPOs as opportunistic plays, not core holdings. Do your due diligence. Understand that a hot IPO can cool rapidly, and a quiet one can surprise.
3. Watch for Interest Rate Trends
REITs are sensitive to interest rates. As central banks consider the next move on rates, expect volatility. For REIT investors, focus on stable income-producing assets, strong sponsors, and low gearing.
4. Monitor SGX Reforms and Market Trends
Singapore’s stock market is evolving. With ERC reforms, tech upgrades, and international investor interest, expect more IPOs, increased liquidity, and a broader asset mix in coming years.
5. Don’t Follow the Herd
One of the most dangerous things is blindly following what seems popular. NTT DC REIT showed that crowd sentiment doesn’t always lead to profits. Make decisions based on logic, not hype.
Conclusion: A Market of Opportunities and Caution
The contrasting fortunes of NTT DC REIT and China Medical System Holdings offer a timely reminder that IPO success depends on fundamentals, timing, and sentiment. As the Singapore stock market charges to new highs, buoyed by reforms and liquidity, investors must navigate the excitement with discipline.
We should not let feel-good headlines be our only guide. Let them spark curiosity — but follow that with research, risk assessment, and realistic return expectations.
For long-term investors, the Singapore market remains attractive — but selectivity and strategy will determine who comes out ahead.
Until next time, stay invested, stay informed!